CoChat
Sign Up
Cited by 61

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit?

Puglielli, Luigi·2008·Neurobiology of Aging
DOI 10.1016/j.neurobiolaging.2007.01.010
Open this paper in CoChat — free account

Abstract

The last decade has revealed that the lifespan of an organism can be modulated by the signaling pathway that acts downstream of the insulin/insulin-like growth factor 1 receptors (IR/IGF1-R), indicating that there is a "program" that drives the process of aging. New results have now linked the same pathway to the neurogenic capacities of the aging brain, to neurotrophin signaling, and to the molecular pathogenesis of Alzheimer's disease. Therefore, a common signaling cascade now seems to link aging to age-associated pathologies of the brain, suggesting that pharmacologic approaches aimed at the modulation of this pathway can serve to delay the onset of age-associated disorders and improve the quality of life. Work from a wide range of fields performed with different approaches has already identified some of the signaling molecules that act downstream of IGF1-R, and has revealed that a delicate checkpoint exists to balance excessive growth/"immortality" and reduced growth/"senescence" of a cell. Future research will determine how far the connection goes and how much of it we can influence.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2007.01.010

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 158

  1. An, 2003, Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease, Am. J. Pathol., 163, 591, 10.1016/S0002-9440(10)63687-5 · DOI · Paper page
  2. Antebi, 2005, Physiology. The tick-tock of aging?, Science, 310, 1911, 10.1126/science.1122816 · DOI
  3. Beckstead, 2006, Indicted: worms caught using steroids, Cell, 124, 1137, 10.1016/j.cell.2006.03.001 · DOI
  4. Bergman, 1999, Effects of aging and axotomy on the expression of neurotrophin receptors in primary sensory neurons, J. Comp. Neurol., 410, 368, 10.1002/(SICI)1096-9861(19990802)410:3<368::AID-CNE2>3.0.CO;2-I · DOI
  5. Berman, 2006, Germ-cell loss extends C. elegans life span through regulation of DAF-16 by kri-1 and lipophilic-hormone signaling, Cell, 124, 1055, 10.1016/j.cell.2006.01.039 · DOI
  6. Berridge, 1987, Inositol trisphosphate and diacylglycerol: two interacting second messengers, Annu. Rev. Biochem., 56, 159, 10.1146/annurev.bi.56.070187.001111 · DOI
  7. Blazer-Yost, 2005, Phosphoinositide lipid second messengers: new paradigms for transepithelial signal transduction, Pflugers Arch., 450, 75, 10.1007/s00424-004-1371-5 · DOI
  8. Bluher, 2003, Extended longevity in mice lacking the insulin receptor in adipose tissue, Science, 299, 572, 10.1126/science.1078223 · DOI · Paper page
  9. Boehm, 2005, A developmental timing microRNA and its target regulate life span in C. elegans, Science, 310, 1954, 10.1126/science.1115596 · DOI
  10. Bondy, 2004, Signaling by insulin-like growth factor 1 in brain, Eur. J. Pharmacol., 490, 25, 10.1016/j.ejphar.2004.02.042 · DOI
  11. Brown-Borg, 2003, Hormonal regulation of aging and life span, Trends Endocrinol. Metab., 14, 151, 10.1016/S1043-2760(03)00051-1 · DOI
  12. Brown-Borg, 1996, Dwarf mice and the ageing process, Nature, 384, 33, 10.1038/384033a0 · DOI
  13. Campisi, 2004, Fragile fugue: p53 in aging, cancer and IGF signaling, Nat. Med., 10, 231, 10.1038/nm0304-231 · DOI
  14. Capsoni, 2006, On the molecular basis linking nerve growth factor (NGF) to Alzheimer's disease, Cell Mol. Neurobiol., 26, 617, 10.1007/s10571-006-9112-2 · DOI
  15. Carro, 2005, Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I, J. Neurosci., 25, 10884, 10.1523/JNEUROSCI.2909-05.2005 · DOI · Paper page
  16. Carro, 2004, The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease, Eur. J. Pharmacol., 490, 127, 10.1016/j.ejphar.2004.02.050 · DOI
  17. Carro, 2006, Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis, Neurobiol. Aging, 27, 1250, 10.1016/j.neurobiolaging.2005.06.015 · DOI
  18. Carro, 2003, Brain repair and neuroprotection by serum insulin-like growth factor I, Mol. Neurobiol., 27, 153, 10.1385/MN:27:2:153 · DOI
  19. Carro, 2006, Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?, Neurobiol. Aging, 27, 1618, 10.1016/j.neurobiolaging.2005.09.039 · DOI
  20. Chung, 2002, Age-related upregulation of insulin-like growth factor receptor type I in rat cerebellum, Neurosci. Lett., 330, 65, 10.1016/S0304-3940(02)00740-1 · DOI
  21. Chung, 2002, Region-specific alterations in insulin-like growth factor receptor type I in the cerebral cortex and hippocampus of aged rats, Brain Res., 946, 307, 10.1016/S0006-8993(02)03041-X · DOI
  22. Costantini, 2005, Ceramide and cholesterol: possible connections between normal aging of the brain and Alzheimer's disease. Just hypotheses or molecular pathways to be identified?, Alzheimer's & Dementia, 1, 43, 10.1016/j.jalz.2005.06.004 · DOI
  23. Costantini, 2006, An aging pathway controls the TrkA to p75(NTR) receptor switch and amyloid beta-peptide generation, EMBO J., 25, 1997, 10.1038/sj.emboj.7601062 · DOI
  24. Costantini, 2005, A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging, Biochem. J., 391, 59, 10.1042/BJ20050700 · DOI
  25. Coulson, 2006, Does the p75 neurotrophin receptor mediate Abeta-induced toxicity in Alzheimer's disease?, J. Neurochem., 98, 654, 10.1111/j.1471-4159.2006.03905.x · DOI
  26. Counts, 2005, The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease, J. Neuropathol. Exp. Neurol., 64, 263, 10.1093/jnen/64.4.263 · DOI
  27. Counts, 2004, Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease, Ann. Neurol., 56, 520, 10.1002/ana.20233 · DOI
  28. Craft, 2003, Insulin dose–response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype, Psychoneuroendocrinology, 28, 809, 10.1016/S0306-4530(02)00087-2 · DOI
  29. Cristofalo, 2004, Replicative senescence: a critical review, Mech. Ageing Dev, 125, 827, 10.1016/j.mad.2004.07.010 · DOI
  30. Cutler, 2004, Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A., 101, 2070, 10.1073/pnas.0305799101 · DOI · Paper page
  31. Czech, 2000, PIP2 and PIP3: complex roles at the cell surface, Cell, 100, 603, 10.1016/S0092-8674(00)80696-0 · DOI
  32. Deane, 2004, Phosphoinositide 3-kinase: diverse roles in immune cell activation, Annu. Rev. Immunol., 22, 563, 10.1146/annurev.immunol.22.012703.104721 · DOI
  33. Dechant, 2002, The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system, Nat. Neurosci., 5, 1131, 10.1038/nn1102-1131 · DOI
  34. Delacourte, 2002, Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease, Neurology, 59, 398, 10.1212/WNL.59.3.398 · DOI
  35. D’Mello, 1994, Cloning and characterization of LAG1, a longevity-assurance gene in yeast, J. Biol. Chem., 269, 15451, 10.1016/S0021-9258(17)40700-9 · DOI
  36. Domeniconi, 2005, MAG induces regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth, Neuron, 46, 849, 10.1016/j.neuron.2005.05.029 · DOI
  37. Dupont, 2003, Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression, Recent Prog. Horm. Res., 58, 325, 10.1210/rp.58.1.325 · DOI
  38. Fahnestock, 2001, The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease, Mol. Cell Neurosci., 18, 210, 10.1006/mcne.2001.1016 · DOI
  39. Federici, 1997, Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues, Mol. Cell Endocrinol., 129, 121, 10.1016/S0303-7207(97)04050-1 · DOI
  40. Federici, 1997, Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients, Mol. Cell Endocrinol., 135, 41, 10.1016/S0303-7207(97)00185-8 · DOI
  41. Flurkey, 2001, Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production, Proc. Natl. Acad. Sci. U.S.A., 98, 6736, 10.1073/pnas.111158898 · DOI · Paper page
  42. Francis, 2002, aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation, Dev. Cell, 3, 85, 10.1016/S1534-5807(02)00189-2 · DOI
  43. Friedman, 1988, A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility, Genetics, 118, 75, 10.1093/genetics/118.1.75 · DOI
  44. Futerman, 1994, Ceramide metabolism compartmentalized in the endoplasmic reticulum and Golgi apparatus, vol. 40, 93
  45. Futerman, 2005, The ins and outs of sphingolipid synthesis, Trends Cell Biol., 15, 312, 10.1016/j.tcb.2005.04.006 · DOI
  46. Galasko, 2003, Insulin and Alzheimer's disease: an amyloid connection, Neurology, 60, 1886, 10.1212/WNL.60.12.1886 · DOI
  47. Gerisch, 2001, A hormonal signaling pathway influencing C. elegans metabolism, reproductive development, and life span, Dev. Cell, 1, 841, 10.1016/S1534-5807(01)00085-5 · DOI
  48. Gibbs, 1998, Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function, Exp. Neurol., 151, 289, 10.1006/exnr.1998.6789 · DOI
  49. Giudici, 2004, Phosphatidylinositol phosphate kinases, J. Endocrinol. Invest., 27, 137
  50. Gotz, 2004, Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy, Mol. Psychiatry, 9, 664, 10.1038/sj.mp.4001508 · DOI
  51. Goutte, 2002, APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos, Proc. Natl. Acad. Sci. U.S.A., 99, 775, 10.1073/pnas.022523499 · DOI
  52. Guan, 2000, Selective neuroprotective effects with insulin-like growth factor-1 in phenotypic striatal neurons following ischemic brain injury in fetal sheep, Neuroscience, 95, 831, 10.1016/S0306-4522(99)00456-X · DOI
  53. Guan, 2000, N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats, Brain Res., 859, 286, 10.1016/S0006-8993(00)01988-0 · DOI
  54. Guillas, 2001, C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p, EMBO J., 20, 2655, 10.1093/emboj/20.11.2655 · DOI
  55. Halstead, 2001, A novel pathway of cellular phosphatidylinositol(3,4,5)-trisphosphate synthesis is regulated by oxidative stress, Curr. Biol., 11, 386, 10.1016/S0960-9822(01)00121-X · DOI
  56. Hanada, 2003, Molecular machinery for non-vesicular trafficking of ceramide, Nature, 426, 803, 10.1038/nature02188 · DOI
  57. Hannun, 2004, Lipid metabolism: ceramide transfer protein adds a new dimension, Curr. Biol., 14, R163, 10.1016/S0960-9822(04)00079-X · DOI
  58. He, 2004, Structure of nerve growth factor complexed with the shared neurotrophin receptor p75, Science, 304, 870, 10.1126/science.1095190 · DOI
  59. Hebert, 2003, Alzheimer disease in the US population: prevalence estimates using the 2000 census, Arch. Neurol., 60, 1119, 10.1001/archneur.60.8.1119 · DOI · Paper page
  60. Henderson, 1997, The epidemiology of estrogen replacement therapy and Alzheimer's disease, Neurology, 48, S27, 10.1212/WNL.48.5_Suppl_7.27S · DOI
  61. Hinchliffe, 2000, Intracellular signalling: is PIP(2) a messenger too?, Curr. Biol., 10, R104, 10.1016/S0960-9822(00)00303-1 · DOI
  62. Hinchliffe, 2001, Cellular signalling: stressing the importance of PIP3, Curr. Biol., 11, R371, 10.1016/S0960-9822(01)00197-X · DOI
  63. Hock, 1998, Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease, Neurosci. Lett., 241, 151, 10.1016/S0304-3940(98)00019-6 · DOI
  64. Hofmann, 2000, Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase, Proc. Natl. Acad. Sci. U.S.A., 97, 5895, 10.1073/pnas.97.11.5895 · DOI
  65. Hsin, 1999, Signals from the reproductive system regulate the lifespan of C. elegans, Nature, 399, 362, 10.1038/20694 · DOI
  66. Hu, 2002, Increased p75(NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients, Exp. Neurol., 178, 104, 10.1006/exnr.2002.8018 · DOI
  67. Hussain, 1999, Identification of a novel aspartic protease (Asp 2) as beta-secretase, Mol. Cell Neurosci., 14, 419, 10.1006/mcne.1999.0811 · DOI · Paper page
  68. Ibanez, 1998, Emerging themes in structural biology of neurotrophic factors, Trends Neurosci., 21, 438, 10.1016/S0166-2236(98)01266-1 · DOI
  69. Insall, 2001, PIP3, PIP2, and cell movement—similar messages, different meanings?, Dev. Cell, 1, 743, 10.1016/S1534-5807(01)00086-7 · DOI
  70. Jaffe, 1994, Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein, J. Biol. Chem., 269, 13065, 10.1016/S0021-9258(17)36796-0 · DOI
  71. Jiang, 1998, Homologs of the yeast longevity gene LAG1 in Caenorhabditis elegans and human, Genome Res., 8, 1259, 10.1101/gr.8.12.1259 · DOI
  72. Johnson, 1999, Expression of p75(NTR), trkB and trkC in nonmanipulated and axotomized motoneurons of aged rats, Brain Res. Mol. Brain Res., 69, 21, 10.1016/S0169-328X(99)00068-6 · DOI
  73. Jones, 1995, Insulin-like growth factors and their binding proteins: biological actions, Endocr. Rev., 16, 3
  74. Jover, 2002, Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1, J. Neurosci., 22, 2115, 10.1523/JNEUROSCI.22-06-02115.2002 · DOI
  75. Jung, 2003, Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor, J. Biol. Chem., 278, 42161, 10.1074/jbc.M306028200 · DOI
  76. Kalb, 2005, The protean actions of neurotrophins and their receptors on the life and death of neurons, Trends Neurosci., 28, 5, 10.1016/j.tins.2004.11.003 · DOI
  77. Kanning, 2003, Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability, J. Neurosci., 23, 5425, 10.1523/JNEUROSCI.23-13-05425.2003 · DOI
  78. Kenyon, 1993, A C. elegans mutant that lives twice as long as wild type, Nature, 366, 461, 10.1038/366461a0 · DOI · Paper page
  79. Kimura, 1997, daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans, Science, 277, 942, 10.1126/science.277.5328.942 · DOI
  80. Klass, 1983, A method for the isolation of longevity mutants in the nematode Caenorhabditis elegans and initial results, Mech. Ageing Dev., 22, 279, 10.1016/0047-6374(83)90082-9 · DOI
  81. Kumagai, 2005, CERT mediates intermembrane transfer of various molecular species of ceramides, J. Biol. Chem., 280, 6488, 10.1074/jbc.M409290200 · DOI
  82. Lanlua, 2001, Female steroid hormones modulate receptors for nerve growth factor in rat dorsal root ganglia, Biol. Reprod., 64, 331, 10.1095/biolreprod64.1.331 · DOI
  83. Lazarov, 2006, Electron microscopic structure of purified, active gamma-secretase reveals an aqueous intramembrane chamber and two pores, Proc. Natl. Acad. Sci. U.S.A., 103, 6889, 10.1073/pnas.0602321103 · DOI
  84. Lesort, 2000, Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons, Neuroscience, 99, 305, 10.1016/S0306-4522(00)00200-1 · DOI
  85. Li, 1997, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer, Science, 275, 1943, 10.1126/science.275.5308.1943 · DOI · Paper page
  86. Lightle, 2000, Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging, Mech. Ageing Dev., 120, 111, 10.1016/S0047-6374(00)00191-3 · DOI
  87. Lin, 1997, daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans, Science, 278, 1319, 10.1126/science.278.5341.1319 · DOI
  88. Lupu, 2001, Roles of growth hormone and insulin-like growth factor 1 in mouse postanatal growth, Dev. Biol., 229, 141, 10.1006/dbio.2000.9975 · DOI
  89. Maehama, 1999, PTEN: a tumour suppressor that functions as a phospholipid phosphatase, Trends Cell Biol., 9, 125, 10.1016/S0962-8924(99)01519-6 · DOI
  90. Maier, 2004, Modulation of mammalian life span by the short isoform of p53, Genes Dev., 18, 306, 10.1101/gad.1162404 · DOI · Paper page
  91. Manly, 2000, Endogenous estrogen levels and Alzheimer's disease among postmenopausal women, Neurology, 54, 833, 10.1212/WNL.54.4.833 · DOI
  92. Marchesini, 2003, Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism, J. Biol. Chem., 278, 13775, 10.1074/jbc.M212262200 · DOI
  93. Medrano, 2005, Maintaining appearances—the role of p53 in adult neurogenesis, Biochem. Biophys. Res. Commun., 331, 828, 10.1016/j.bbrc.2005.03.194 · DOI
  94. Mi, 2004, LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex, Nat. Neurosci., 7, 221, 10.1038/nn1188 · DOI
  95. Miller, 2001, Human diploid fibroblasts that undergo a senescent-like differentiation have elevated ceramide and diacylglycerol, J. Gerontol. A: Biol. Sci. Med. Sci., 56, B8, 10.1093/gerona/56.1.B8 · DOI
  96. Morris, 1999, Is Alzheimer's disease inevitable with age? Lessons from clinicopathologic studies of healthy aging and very mild Alzheimer's disease, J. Clin. Invest., 104, 1171, 10.1172/JCI8560 · DOI · Paper page
  97. Motola, 2006, Identification of ligands for DAF-12 that govern dauer formation and reproduction in C. elegans, Cell, 124, 1209, 10.1016/j.cell.2006.01.037 · DOI
  98. Mouton, 2000, Ceramide induces expression of the senescence histochemical marker, beta-galactosidase, in human fibroblasts, Mech. Ageing Dev., 113, 169, 10.1016/S0047-6374(99)00105-0 · DOI · Paper page
  99. Mufson, 2002, Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease, Neurochem. Res., 27, 1035, 10.1023/A:1020952704398 · DOI
  100. Mufson, 2003, Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction, J. Chem. Neuroanat., 26, 233, 10.1016/S0891-0618(03)00068-1 · DOI
  101. Mufson, 1992, Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 89, 569, 10.1073/pnas.89.2.569 · DOI
  102. Munro, 2003, Cell biology: earthworms and lipid couriers, Nature, 426, 775, 10.1038/426775a · DOI
  103. Myers, 1998, The lipid phosphatase activity of PTEN is critical for its tumor suppressor function, Proc. Natl. Acad. Sci. U.S.A., 95, 13513, 10.1073/pnas.95.23.13513 · DOI
  104. Nilsson-Hakansson, 1993, Effects of IGF-1, truncated IGF-1 and the tripeptide Gly-Pro-Glu on acetylcholine release from parietal cortex of rat brain, Neuroreport, 4, 1111
  105. Nykjaer, 2005, p75NTR—live or let die, Curr. Opin. Neurobiol., 15, 49, 10.1016/j.conb.2005.01.004 · DOI · Paper page
  106. Ogg, 1997, The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans, Nature, 389, 994, 10.1038/40194 · DOI
  107. Ogura, 2006, Three-dimensional structure of the gamma-secretase complex, Biochem. Biophys. Res. Commun., 343, 525, 10.1016/j.bbrc.2006.02.158 · DOI
  108. Peng, 2004, Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease, J. Neuropathol. Exp. Neurol., 63, 641, 10.1093/jnen/63.6.641 · DOI
  109. Petanceska, 2000, Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain, Neurology, 54, 2212, 10.1212/WNL.54.12.2212 · DOI
  110. Ping, 2002, Estrogen treatment suppresses forebrain p75 neurotrophin receptor expression in aged, noncycling female rats, J. Neurosci. Res., 69, 51, 10.1002/jnr.10273 · DOI
  111. Plo, 2004, Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling, J. Neurosci. Res., 77, 465, 10.1002/jnr.20189 · DOI
  112. Puglielli, 2003, Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis, J. Biol. Chem., 278, 19777, 10.1074/jbc.M300466200 · DOI
  113. Puglielli, 2003, Alzheimer's disease: the cholesterol connection, Nat. Neurosci., 6, 345, 10.1038/nn0403-345 · DOI · Paper page
  114. Reinhardt, 1994, Insulin-like growth factors cross the blood-brain barrier, Endocrinology, 135, 1753, 10.1210/en.135.5.1753 · DOI
  115. Rottiers, 2006, Hormonal control of C. elegans dauer formation and life span by a Rieske-like oxygenase, Dev. Cell, 10, 473, 10.1016/j.devcel.2006.02.008 · DOI
  116. Sandhoff, 1994, Metabolism of gangliosides: topology, pathobiochemistry, and sphingolipid activator proteins, vol. 40, 75
  117. SantaCruz, 2005, Tau suppression in a neurodegenerative mouse model improves memory function, Science, 309, 476, 10.1126/science.1113694 · DOI · Paper page
  118. Sara, 1989, Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptide, Biochem. Biophys. Res. Commun., 165, 766, 10.1016/S0006-291X(89)80032-4 · DOI
  119. Schorling, 2001, Lag1p and Lac1p are essential for the Acyl-CoA-dependent ceramide synthase reaction in Saccharomyces cerevisae, Mol. Biol. Cell, 12, 3417, 10.1091/mbc.12.11.3417 · DOI
  120. Schubert, 2003, Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation, J. Neurosci., 23, 7084, 10.1523/JNEUROSCI.23-18-07084.2003 · DOI · Paper page
  121. Scrable, 2005, DeltaNp53 or p44: priming the p53 pump, Int. J. Biochem. Cell Biol., 37, 913, 10.1016/j.biocel.2004.11.014 · DOI
  122. Selkoe, 1999, Translating cell biology into therapeutic advances in Alzheimer's disease, Nature, 399, A23, 10.1038/19866 · DOI
  123. Shay, 2000, Hayflick, his limit, and cellular ageing, Nat. Rev. Mol. Cell. Biol., 1, 72, 10.1038/35036093 · DOI · Paper page
  124. Sinha, 1999, Purification and cloning of amyloid precursor protein beta-secretase from human brain, Nature, 402, 537, 10.1038/990114 · DOI · Paper page
  125. Smith, 1996, Replicative senescence: implications for in vivo aging and tumor suppression, Science, 273, 63, 10.1126/science.273.5271.63 · DOI · Paper page
  126. Sohal, 1996, Oxidative stress, caloric restriction, and aging, Science, 273, 59, 10.1126/science.273.5271.59 · DOI
  127. Stambolic, 1998, Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN, Cell, 95, 29, 10.1016/S0092-8674(00)81780-8 · DOI · Paper page
  128. Stenvers, 1996, Increased expression of type 1 insulin-like growth factor receptor messenger RNA in rat hippocampal formation is associated with aging and behavioral impairment, Neuroscience, 72, 505, 10.1016/0306-4522(95)00524-2 · DOI
  129. Sun, 2005, Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice, Neurobiol. Aging, 26, 929, 10.1016/j.neurobiolaging.2004.07.010 · DOI
  130. Sytze van Dam, 2004, Insulin-like growth factor-I, cognition and brain aging, Eur. J. Pharmacol., 490, 87, 10.1016/j.ejphar.2004.02.047 · DOI
  131. Tamura, 1998, Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN, Science, 280, 1614, 10.1126/science.280.5369.1614 · DOI · Paper page
  132. Tarr, 2002, Evidence for a role of the nerve growth factor receptor TrkA in tyrosine phosphorylation and processing of beta-APP, Biochem. Biophys. Res. Commun., 295, 324, 10.1016/S0006-291X(02)00678-2 · DOI
  133. Tatar, 2001, A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function, Science, 292, 107, 10.1126/science.1057987 · DOI
  134. Tissenbaum, 2002, Model organisms as a guide to mammalian aging, Dev. Cell, 2, 9, 10.1016/S1534-5807(01)00098-3 · DOI
  135. Tschape, 2002, The neurodegeneration mutant lochrig interferes with cholesterol homeostasis and Appl processing, EMBO J., 21, 6367, 10.1093/emboj/cdf636 · DOI
  136. Ullrich, 1986, Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity, EMBO J., 5, 2503, 10.1002/j.1460-2075.1986.tb04528.x · DOI
  137. Vanhaesebroeck, 2001, Synthesis and function of 3-phosphorylated inositol lipids, Annu. Rev. Biochem., 70, 535, 10.1146/annurev.biochem.70.1.535 · DOI · Paper page
  138. Venable, 1995, Role of ceramide in cellular senescence, J. Biol. Chem., 270, 30701, 10.1074/jbc.270.51.30701 · DOI
  139. Venable, 1999, Phospholipase D in cellular senescence, Biochim. Biophys. Acta, 1439, 291, 10.1016/S1388-1981(99)00101-8 · DOI
  140. Venkataraman, 2000, Ceramide as a second messenger: sticky solutions to sticky problems, Trends Cell Biol., 10, 408, 10.1016/S0962-8924(00)01830-4 · DOI
  141. Walsh, 2004, Deciphering the molecular basis of memory failure in Alzheimer's disease, Neuron, 44, 181, 10.1016/j.neuron.2004.09.010 · DOI · Paper page
  142. Watson, 2003, Insulin increases CSF Abeta42 levels in normal older adults, Neurology, 60, 1899, 10.1212/01.WNL.0000065916.25128.25 · DOI
  143. Weindruch, 1997, Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging, N. Engl. J. Med., 337, 986, 10.1056/NEJM199710023371407 · DOI
  144. Werther, 1990, Localization of insulin-like growth factor-I mRNA in rat brain by in situ hybridization-relationship to IGF-I receptors, Mol. Endocrinol., 4, 773, 10.1210/mend-4-5-773 · DOI
  145. Werther, 1987, Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry, Endocrinology, 121, 1562, 10.1210/endo-121-4-1562 · DOI
  146. Weskamp, 2004, Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR), J. Biol. Chem., 279, 4241, 10.1074/jbc.M307974200 · DOI
  147. Xu, 1998, Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides, Nat. Med., 4, 447, 10.1038/nm0498-447 · DOI
  148. Yamamoto, 1994, Generation of des-(1-3) insulin-like growth factor-I in serum by an acid protease, Endocrinology, 135, 2432, 10.1210/en.135.6.2432 · DOI
  149. Yamamoto, 1995, Enzymatic conversion of IGF-I to des(1-3)IGF-I in rat serum and tissues: a further potential site of growth hormone regulation of IGF-I action, J. Endocrinol., 146, 141, 10.1677/joe.0.1460141 · DOI
  150. Yamamoto, 1995, N-Terminal truncated insulin-like growth factor-I in human urine, J. Clin. Endocrinol. Metab., 80, 1179, 10.1210/jc.80.4.1179 · DOI
  151. Yan, 1999, Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity, Nature, 402, 533, 10.1038/990107 · DOI · Paper page
  152. Yang, 2004, Ceramide and other sphingolipids in cellular responses, Cell Biochem. Biophys., 40, 323, 10.1385/CBB:40:3:323 · DOI
  153. Yu, 2000, Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing, Nature, 407, 48, 10.1038/35024009 · DOI
  154. Zampieri, 2004, Structural biology. The p75 NGF receptor exposed, Science, 304, 833, 10.1126/science.1098110 · DOI
  155. Zhang, 1997, Phosphatidylinositol-4-phosphate 5-kinase isozymes catalyze the synthesis of 3-phosphate-containing phosphatidylinositol signaling molecules, J. Biol. Chem., 272, 17756, 10.1074/jbc.272.28.17756 · DOI
  156. Zheng, 2002, Modulation of A(beta) peptides by estrogen in mouse models, J. Neurochem., 80, 191, 10.1046/j.0022-3042.2001.00690.x · DOI
  157. Zhou, 2005, CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production, Proc. Natl. Acad. Sci. U.S.A., 102, 7499, 10.1073/pnas.0502768102 · DOI
  158. Zumbansen, 2002, Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease, Mol. Cell Biol., 22, 3633, 10.1128/MCB.22.11.3633-3638.2002 · DOI

Cited by

Sorted by citations

Metadata

Authors
Puglielli, L.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2008-06
Volume
29
Issue
6
Pages
795-811
ISSN
0197-4580
DOI
10.1016/j.neurobiolaging.2007.01.010
Cited by
61
References
18
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review